Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy
Anticancer Research · 2024
DOI: 10.21873/anticanres.17282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Takashi Oshima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; oshimat@kcch.jp. Hauptthemen laut MEDLINE: Stomach Neoplasms, Granzymes, Gastrectomy, Neoplasm Staging.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; oshimat@kcch.jp.
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
- Department of Surgery, Yokohama City University, Yokohama, Japan.
- Kanagawa Cancer Center Research Institute, Yokohama, Japan.
- Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.
Zitieren
APA
Oshima, T., Hashimoto, I., Hiroshima, Y., Kimura, Y., Tanabe, M., Nakayama, Y., Nagasawa, S., Kanematsu, K., Aoyama, T., Yamada, T., Ogata, T., & Miyagi, Y. (2024). Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy. Anticancer Research. https://doi.org/10.21873/anticanres.17282
Vancouver
Oshima T, Hashimoto I, Hiroshima Y, Kimura Y, Tanabe M, Nakayama Y, et al. Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy. Anticancer Research. 2024. doi:10.21873/anticanres.17282
BibTeX
@article{Oshima2024,
author = {Oshima, Takashi and Hashimoto, Itaru and Hiroshima, Yukihiko and Kimura, Yayoi and Tanabe, Mie and Nakayama, Yuta and Nagasawa, Shinsuke and Kanematsu, Kyohei and Aoyama, Toru and Yamada, Takanobu and Ogata, Takashi and Miyagi, Yohei},
title = {Clinical Significance of Granzyme B Gene Expression in Pathological Stage II/III Gastric Cancer After Curative Gastrectomy},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17282}
}
EUVIMED